(Q39129217)

9 September 2017

title

Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action (English)

1 reference

9 September 2017

7

H A Katus

1 reference

9 September 2017

F Fischer

1

1 reference

9 September 2017

N Vonderlin

2

1 reference

9 September 2017

E Zitron

3

1 reference

9 September 2017

C Seyler

4

1 reference

9 September 2017

D Scherer

5

1 reference

9 September 2017

R Becker

6

1 reference

9 September 2017

E P Scholz

8

1 reference

9 September 2017

publication date

6 July 2013

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

9 September 2017

published in

1 reference

9 September 2017

volume

386

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

991-999

1 reference

"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Atrial-selective approaches for the treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

On the mechanism of drug-induced blockade of Na+ currents: interaction of antiarrhythmic compounds with DPI-modified single cardiac Na+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Heterogeneous expression of KChIP2 isoforms in the ferret heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Central role of PKCα in isoenzyme-selective regulation of cardiac transient outward current Ito and Kv4.3 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Extracellular acidosis modulates drug block of Kv4.3 currents by flecainide and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Molecular aspects of adrenergic modulation of the transient outward current.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Potential molecular basis of different physiological properties of the transient outward K+ current in rabbit and human atrial myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-013-0901-0

Effect of ajmaline on transient outward current in rat ventricular myocytes.

21 January 2018

1 reference

12 December 2020

NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres

1 reference

12 December 2020

Vernakalant: a new drug to treat patients with acute onset atrial fibrillation

1 reference

12 December 2020

Antiarrhythmics. VI. Ajmaline and serpentine in experimental cardiac arrhythmias

1 reference

12 December 2020

Use-dependent blockade of sodium channels by local anaesthetics and antiarrhythmic drugs. Effects of chloramine-T and calcium ions.

1 reference

12 December 2020

Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes

1 reference

12 December 2020

Comparative study on the proarrhythmic effects of some antiarrhythmic agents

1 reference

12 December 2020

Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.

1 reference

12 December 2020

Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome

1 reference

12 December 2020

Distinct domains of the voltage-gated K+ channel Kv beta 1.3 beta-subunit affect voltage-dependent gating.

1 reference

12 December 2020

Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia

1 reference

12 December 2020

Blockade of sodium and potassium channels in the node of Ranvier by ajmaline and N-propyl ajmaline

1 reference

12 December 2020

10.1007/S00210-013-0901-0

Identifiers

DOI

1 reference

9 September 2017

1 reference